Skip to main content
Have a personal or library account? Click to login
Major drivers influencing adherence and quality of life during antiviral triple therapy in patients with chronic hepatitis C Cover

Major drivers influencing adherence and quality of life during antiviral triple therapy in patients with chronic hepatitis C

ARS Medica Tomitana
Volume 22 (2016): Issue 2 (May 2016)
By: ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Aug 2016
References

References

  1. 1. WHO. (1999). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 6(1), 35-47.
    Search in Google Scholar
  2. 2. McHutchison, J.G., Manns, M.P., Muir, A.J., Terrault, N.A., Jacobson, I.M., Afdhal, N.H., Heathcote, E.J., Zeuzem, S., Reesink, H.W., Garg, J., Bsharat, M., George, S., Kauffman, R.S., Adda, N., Di Bisceglie, A.M. & Team, P.S. (2010). Telaprevir for previously treated chronic HCV infection. N Engl J Med. 362(14), 1292-1303. doi: 10.1056/NEJMoa0908014.
    Open DOISearch in Google Scholar
  3. 3. Muir, A.J., Poordad, F.F., McHutchison, J.G., Shiffman, M.L., Berg, T., Ferenci, P., Heathcote, E.J., Pawlotsky, J.M., Zeuzem, S., Reesink, H.W., Dusheiko, G., Martin, E.C., George, S., Kauffman, R.S. & Adda, N. (2011). Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response. Hepatology. 54(5), 1538-1546. doi: 10.1002/hep.24549.
    Open DOISearch in Google Scholar
  4. 4. Perry, C.M. (2012). Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C. Drugs. 72(5), 619-641. doi: 10.2165/11208370-000000000-00000.
    Open DOISearch in Google Scholar
  5. 5. Ascione, A. (2012). Boceprevir in chronic hepatitis C infection: a perspective review. Ther Adv Chronic Dis. 3(3), 113-121. doi: 10.1177/2040622312441496.
    Open DOISearch in Google Scholar
  6. 6. Leroy, V., Serfaty, L., Bourliere, M., Bronowicki, J.P., Delasalle, P., Pariente, A., Pol, S., Zoulim, F., Pageaux, G.P. & French Association for the Study of the, L. (2012). Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver. Liver Int. 32(10), 1477-1492. doi: 10.1111/j.1478-3231.2012.02856.x.
    Open DOISearch in Google Scholar
  7. 7. Matthews, S.J. & Lancaster, J.W. (2012). Telaprevir: a hepatitis C NS3/4A protease inhibitor. Clin Ther. 34(9), 1857-1882. doi: 10.1016/j.clinthera.2012.07.011.
    Open DOISearch in Google Scholar
  8. 8. Claxton, A.J., Cramer, J. & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 23(8), 1296-1310.
    Open DOISearch in Google Scholar
  9. 9. Buring, S.M., Winner, L.H., Hatton, R.C. & Doering, P.L. (1999). Discontinuation rates of Helicobacter pylori treatment regimens: a metaanalysis. Pharmacotherapy. 19(3), 324-332.
    Open DOISearch in Google Scholar
  10. 10. Connor, J., Rafter, N. & Rodgers, A. (2004). Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ. 82(12), 935-939. doi: /S0042-96862004001200010.
    Search in Google Scholar
  11. 11. Iskedjian, M., Einarson, T.R., MacKeigan, L.D., Shear, N., Addis, A., Mittmann, N. & Ilersich, A.L. (2002). Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a metaanalysis. Clin Ther. 24(2), 302-316.
    Open DOISearch in Google Scholar
  12. 12. Richter, A., Anton, S.F., Koch, P. & Dennett, S.L. (2003). The impact of reducing dose frequency on health outcomes. Clin Ther. 25(8), 2307-2335.
    Open DOISearch in Google Scholar
  13. 13. Yildiz, A., Pauler, D.K. & Sachs, G.S. (2004). Rates of study completion with single versus split daily dosing of antidepressants: a metaanalysis. J Affect Disord. 78(2), 157-162.
    Open DOISearch in Google Scholar
  14. 14. van Dulmen, S., Sluijs, E., van Dijk, L., de Ridder, D., Heerdink, R. & Bensing, J. (2007). Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 7, 55. doi: 10.1186/1472-6963-7-55.
    Open DOISearch in Google Scholar
  15. 15. Special report: interventions to improve patient adherence with medications for chronic cardiovascular disorders. (2003). TEC Bull (Online). 20(3), 30-32.
    Search in Google Scholar
  16. 16. DiMatteo, M.R. (2004). Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 42(3), 200-209.
    Open DOISearch in Google Scholar
  17. 17. Vergouwen, A.C., Bakker, A., Katon, W.J., Verheij, T.J. & Koerselman, F. (2003). Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 64(12), 1415-1420.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/arsm-2016-0015 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Journal RSS Feed
Language: English
Page range: 83 - 91
Published on: Aug 19, 2016
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
adherence,
quality of life,
triple therapy
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2016 Andra I. Suceveanu, Laura Mazilu, Victoria Arama, A. P. Suceveanu, Irinel R. Parepa, Alina Cenusa, A. Catinean, L. Craciun, F. Voinea, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 22 (2016): Issue 2 (May 2016)
Previous article
Next article